2. Signaling Pathways
  3. Cell Cycle/DNA Damage
  4. CDK
  5. CDK Isoform
  6. CDK Control

CDK Control

CDK Control (1):

Cat. No. Product Name Effect Purity
  • HY-100888A
    (R)-Simurosertib
    		Control 99.58%
    (R)-Simurosertib ((R)-TAK-931) is the (R)-enantiomer of Simurosertib. Simurosertib (TAK-931) is an orally active, selective and ATP-competitive cell division cycle 7 (CDC7) kinase inhibitor, with an IC50 of <0.3 nM .